Healthcare

Explore ASX Penny Stocks Highlighting Mayne Pharma Group and Two Mor...

Exploring ASX Penny Stocks Amid Market Dynamics

EZZ Life Science (ASX:EZZ) Lags, But Strong Financials Signal Potent...

EZZ Life Science Holdings Limited (ASX:EZZ) Stock Has Been Underperforming Recently, Yet Financials Show Strength: Is It a Good Opportunity for Potent...

Why Is This Low-Key Stock Suddenly Making Waves?

Highlights:,Blinklab Initiates FDA Study:,Blinklab (ASX:BB1) has launched an FDA registrational study for its Dx 1 platform, aimed at improving autism...

ASX Quarterly Health Update: Bioxyne Sees 77% Revenue Increase, Radi...

Highlights:,Bioxyne (ASX:BXN) achieves significant revenue growth with expanded product offerings.,Radiopharm Theranostics (ASX:RAD) makes progress wi...

AdAlta strengthens leadership in the second quarter of fiscal year 2...

Highlights,AdAlta expands leadership team with new board members and advisors to enhance growth plans.,First non-binding term sheet signed for East to...

Bio-Gene Secures U.S. Defence Contracts for Innovative Insecticides,...

Highlights,Major U.S. Defence Grants:,Bio-Gene Technology receives $3 million in contracts to develop its flagship insecticides.,Wearable Insecticide:...

Is Mesoblast Revolutionizing Stem-Cell Therapy for Inflammatory Dise...

Highlights:,Mesoblast's Ryoncil therapy gains FDA approval for treating children with steroid-resistant Graft-versus-Host Disease (GvHD).,The company...

When Might Cyclopharm Limited (ASX:CYC) Become Profitable?

Highlights,Cyclopharm Limited is nearing breakeven,Average annual growth rate of 105% expected,No debt on balance sheet,Cyclopharm Limited (,ASX: CYC,...

Sigma Healthcare Shares Surge 10% Amid Strong Merger Partner Perform...

Highlights,Sigma Healthcare shares rise 10.2% to AU$2.975, marking their highest level since January 14, as merger news boosts investor confidence.,Ch...

Arovella Therapeutics (ASX:ALA) Surges with 71% CAGR in Three Years,...

Arovella Therapeutics (ASX:ALA) has provided its shareholders with an impressive compound annual growth rate (CAGR) of 71% over the past three years,...

Radiopharmaceutical Expansion Sparks Telix Pharmaceuticals (ASX:TLX)...

Highlights:,Acquisition of RLS,Radiopharmacies,bolsters commercial infrastructure and distribution in the US,Telix,Pharmaceuticals (,ASX:TLX,) records...

Health Check: Alterity Seeks Accelerated FDA Approval Following Posi...

Breakthroughs and Market Movements in Medical Innovations

Imricor Secures CE Mark Certification for Vision-MR Ablation Cathete...

Imricor Secures CE Mark Certification for Vision-MR Ablation Catheter under New MDR Standards

What Makes This Hidden Stock the Center of Attention Right Now?

Highlights:,Bio-Gene Technology secures US military grants for natural insecticide development.,ASX biotech companies show impressive revenue growth.,...

Could Wellnex's Global Expansion Transform Healthcare Branding?

Highlights,Wellnex (ASX:WNX) secures funds for a secondary listing in London.,Transition from a brand broker to an owner of consumer healthcare brands...

Is Cochlear Limited's (ASX:COH) Recent Stock Performance Driven by I...

Headlines,Significant stock increase observed for Cochlear Limited (,ASX:COH,).,The company showcases impressive Return on Equity (ROE).,Maintains ste...

Is BlinkLab's Dx 1 Platform Set to Redefine Autism Diagnostics?

Highlights,BlinkLab (ASX:BB1) embarks on a US autism diagnostic trial in collaboration with two respected clinical centers.,The trial evaluates the Dx...

Can EBR Systems Revolutionize Cardiac Care?

Highlights,EBR Systems (ASX:EBR) awaits regulatory authorization for an innovative leadless pacemaker.,The device transforms ultrasound energy into ta...

AI-Powered Lung Disease Diagnosis Achieves 96.57% Accuracy

Highlights:,AI model achieves 96.57% accuracy in diagnosing respiratory diseases through lung ultrasound analysis.,The model provides visual explanati...

Clarity Pharmaceuticals (ASX:CU6) Gains FDA Fast Track Status for PE...

Highlights,Clarity Pharmaceuticals (ASX:CU6) secures FDA fast-track designation for its Cu-64 SAR-,bisPSMA,imaging agent targeting recurrent prostate...